Clinical Trial Update: DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) [NA]

View source ↗

Summary

ClinicalTrials.gov entry reports the completed DAVID II trial evaluating dual-chamber and VVI implantable defibrillators. The sponsor is Abbott Medical Devices,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Sudden Cardiac Death
• Ventricular Fibrillation
• Ventricular Tachycardia

Snippet

Sponsor: Abbott Medical Devices | Conditions: Ventricular Tachycardia, Ventricular Fibrillation | NA | Status: COMPLETED